abrdn European Equity Tracker Fund X IncRegister to Unlock Ratings |
Performance History | 30/04/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | - | 16.1 | -6.8 | 15.0 | 5.2 | |
+/-Cat | - | 0.7 | 2.0 | 1.5 | 0.6 | |
+/-B’mrk | - | -1.1 | 0.7 | 0.0 | 0.4 | |
Category: Europe ex-UK Equity | ||||||
Category Benchmark: Morningstar DM Eur xUK TME ... |
Key Stats | ||
NAV 17/05/2024 | GBP 1.31 | |
Day Change | -0.67% | |
Morningstar Category™ | Europe ex-UK Equity | |
IA (formerly IMA) Sector | Europe Excluding UK | |
ISIN | GB00BLFBWY29 | |
Fund Size (Mil) 16/05/2024 | GBP 410.20 | |
Share Class Size (Mil) 17/05/2024 | GBP 0.00 | |
Max Initial Charge | - | |
Ongoing Charge 10/05/2024 | 0.06% |
Investment Objective: abrdn European Equity Tracker Fund X Inc |
To generate growth over the long term (5 years or more) by tracking the return of the MSCI Europe ex UK Index. The fund will invest at least 90% in equities (company shares) and equity related securities (such as depositary receipts) of companies that make up the MSCI Europe ex UK Index. The fund will typically invest directly but may also invest indirectly when deemed appropriate in order to meet its objective. Indirect investment may be achieved via derivatives. |
Returns | ||||||||||||||||
|
Management | ||
Manager Name Start Date | ||
Not Disclosed 01/03/2019 | ||
Inception Date 17/07/2020 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI Europe Ex UK NR GBP | Morningstar DM Eur xUK TME NR EUR |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for abrdn European Equity Tracker Fund X Inc | 30/04/2024 |
|
|
Top 5 Holdings | Sector | % |
Novo Nordisk A/S Class B | Healthcare | 5.04 |
ASML Holding NV | Technology | 4.28 |
Nestle SA | Consumer Defensive | 3.20 |
Lvmh Moet Hennessy Louis Vuitton SE | Consumer Cyclical | 2.73 |
Novartis AG Registered Shares | Healthcare | 2.37 |
Increase Decrease New since last portfolio | ||
abrdn European Equity Tracker Fund X Inc |